Tyrvaya
| Tyrvaya | |
|---|---|
| DOSAGE | 1 spray in each nostril BID |
| GENERIC | Varenicline solution 0.03 mg |
| SIZE | 4.2 mL nasal spray |
| INDICATIONS | TYRVAYA (varenicline solution) nasal spray is indicated for the treatment of the signs and symptoms of dry eye disease. |
| MECHANISM OF ACTION | Nicotinic acetylcholine agonist |
| MICROBIOLOGY | Produces acetylcholine agonist activity and activates the trigeminal parasympathetic pathway resulting in increased production of basal tear film as a treatment for dry eye disease. |
| CONTRAINDICATIONS & WARNINGS | None |
| PEDIATRIC USE | Safety and effectiveness in pediatric patients have not been established. |
| PREGNANCY | Not established. Varenicline in other form has been designated pregnancy category C |
| NOTE | |